These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Autophagy inhibition as a potential future targeted therapy for ETV6-RUNX1-driven B-cell precursor acute lymphoblastic leukemia. Polak R; Bierings MB; van der Leije CS; Sanders MA; Roovers O; Marchante JRM; Boer JM; Cornelissen JJ; Pieters R; den Boer ML; Buitenhuis M Haematologica; 2019 Apr; 104(4):738-748. PubMed ID: 30381299 [TBL] [Abstract][Full Text] [Related]
4. ETV6-RUNX1 interacts with a region in SPIB intron 1 to regulate gene expression in pre-B-cell acute lymphoblastic leukemia. Xu LS; Francis A; Turkistany S; Shukla D; Wong A; Batista CR; DeKoter RP Exp Hematol; 2019 May; 73():50-63.e2. PubMed ID: 30986496 [TBL] [Abstract][Full Text] [Related]
5. ETV6/RUNX1 induces reactive oxygen species and drives the accumulation of DNA damage in B cells. Kantner HP; Warsch W; Delogu A; Bauer E; Esterbauer H; Casanova E; Sexl V; Stoiber D Neoplasia; 2013 Nov; 15(11):1292-300. PubMed ID: 24339741 [TBL] [Abstract][Full Text] [Related]
6. Novel ETV6-RUNX1 Mouse Model to Study the Role of ELF-MF in Childhood B-Acute Lymphoblastic Leukemia: a Pilot Study. Campos-Sanchez E; Vicente-Dueñas C; Rodríguez-Hernández G; Capstick M; Kuster N; Dasenbrock C; Sánchez-García I; Cobaleda C Bioelectromagnetics; 2019 Jul; 40(5):343-353. PubMed ID: 31157932 [TBL] [Abstract][Full Text] [Related]
7. Unique long non-coding RNA expression signature in ETV6/RUNX1-driven B-cell precursor acute lymphoblastic leukemia. Ghazavi F; De Moerloose B; Van Loocke W; Wallaert A; Helsmoortel HH; Ferster A; Bakkus M; Plat G; Delabesse E; Uyttebroeck A; Van Nieuwerburgh F; Deforce D; Van Roy N; Speleman F; Benoit Y; Lammens T; Van Vlierberghe P Oncotarget; 2016 Nov; 7(45):73769-73780. PubMed ID: 27650541 [TBL] [Abstract][Full Text] [Related]
8. Cytoskeletal regulatory gene expression and migratory properties of B-cell progenitors are affected by the ETV6-RUNX1 rearrangement. Palmi C; Fazio G; Savino AM; Procter J; Howell L; Cazzaniga V; Vieri M; Longinotti G; Brunati I; Andrè V; Della Mina P; Villa A; Greaves M; Biondi A; D'Amico G; Ford A; Cazzaniga G Mol Cancer Res; 2014 Dec; 12(12):1796-806. PubMed ID: 25061103 [TBL] [Abstract][Full Text] [Related]
9. Coexistence of ETV6/RUNX1 and MLL aberrations in B-cell precursor acute lymphoblastic leukemia discloses a small subclass of BCP-ALL. Amare Kadam PS; Raje GC; Pais AP; Banavali S Cancer Genet Cytogenet; 2008 Apr; 182(1):27-32. PubMed ID: 18328947 [TBL] [Abstract][Full Text] [Related]
10. TEL-AML1 transgenic zebrafish model of precursor B cell acute lymphoblastic leukemia. Sabaawy HE; Azuma M; Embree LJ; Tsai HJ; Starost MF; Hickstein DD Proc Natl Acad Sci U S A; 2006 Oct; 103(41):15166-71. PubMed ID: 17015828 [TBL] [Abstract][Full Text] [Related]
11. Discontinuation of L-asparaginase and poor response to prednisolone are associated with poor outcome of ETV6-RUNX1-positive pediatric B-cell precursor acute lymphoblastic leukemia. Usami I; Imamura T; Takahashi Y; Suenobu SI; Hasegawa D; Hashii Y; Deguchi T; Hori T; Shimada A; Kato K; Ito E; Moriya-Saito A; Kawasaki H; Hori H; Yumura-Yagi K; Hara J; Sato A; Horibe K; Int J Hematol; 2019 Apr; 109(4):477-482. PubMed ID: 30689137 [TBL] [Abstract][Full Text] [Related]
12. A Double Negative Loop Comprising ETV6/RUNX1 and MIR181A1 Contributes to Differentiation Block in t(12;21)-Positive Acute Lymphoblastic Leukemia. Yang YL; Yen CT; Pai CH; Chen HY; Yu SL; Lin CY; Hu CY; Jou ST; Lin DT; Lin SR; Lin SW PLoS One; 2015; 10(11):e0142863. PubMed ID: 26580398 [TBL] [Abstract][Full Text] [Related]
13. ETV6/RUNX1-like acute lymphoblastic leukemia: A novel B-cell precursor leukemia subtype associated with the CD27/CD44 immunophenotype. Zaliova M; Kotrova M; Bresolin S; Stuchly J; Stary J; Hrusak O; Te Kronnie G; Trka J; Zuna J; Vaskova M Genes Chromosomes Cancer; 2017 Aug; 56(8):608-616. PubMed ID: 28395118 [TBL] [Abstract][Full Text] [Related]
14. Modeling the evolution of ETV6-RUNX1-induced B-cell precursor acute lymphoblastic leukemia in mice. van der Weyden L; Giotopoulos G; Rust AG; Matheson LS; van Delft FW; Kong J; Corcoran AE; Greaves MF; Mullighan CG; Huntly BJ; Adams DJ Blood; 2011 Jul; 118(4):1041-51. PubMed ID: 21628403 [TBL] [Abstract][Full Text] [Related]
15. Tumor suppressor BTG1 limits activation of BCL6 expression downstream of ETV6-RUNX1. Tijchon E; van Emst L; Yuniati L; van Ingen Schenau D; Gerritsen M; van der Meer LT; Williams O; Hoogerbrugge PM; Scheijen B; van Leeuwen FN Exp Hematol; 2018 Apr; 60():57-62.e3. PubMed ID: 29408281 [TBL] [Abstract][Full Text] [Related]
16. RUNX1 aberrations in ETV6/RUNX1-positive and ETV6/RUNX1-negative patients: its hemato-pathological and prognostic significance in a large cohort (619 cases) of ALL. Pais AP; Amare Kadam PS; Raje GC; Banavali S; Parikh P; Kurkure P; Arora B; Gujral S; Kumar SA; Badrinath Y Pediatr Hematol Oncol; 2008 Sep; 25(6):582-97. PubMed ID: 18728978 [TBL] [Abstract][Full Text] [Related]
17. ETV6-RUNX1 promotes survival of early B lineage progenitor cells via a dysregulated erythropoietin receptor. Torrano V; Procter J; Cardus P; Greaves M; Ford AM Blood; 2011 Nov; 118(18):4910-8. PubMed ID: 21900195 [TBL] [Abstract][Full Text] [Related]
18. Clonal origins of ETV6-RUNX1⁺ acute lymphoblastic leukemia: studies in monozygotic twins. Alpar D; Wren D; Ermini L; Mansur MB; van Delft FW; Bateman CM; Titley I; Kearney L; Szczepanski T; Gonzalez D; Ford AM; Potter NE; Greaves M Leukemia; 2015 Apr; 29(4):839-46. PubMed ID: 25388957 [TBL] [Abstract][Full Text] [Related]
19. Somatic drivers of B-ALL in a model of ETV6-RUNX1; Pax5(+/-) leukemia. van der Weyden L; Giotopoulos G; Wong K; Rust AG; Robles-Espinoza CD; Osaki H; Huntly BJ; Adams DJ BMC Cancer; 2015 Aug; 15():585. PubMed ID: 26269126 [TBL] [Abstract][Full Text] [Related]
20. The Landscape of Secondary Genetic Rearrangements in Pediatric Patients with B-Cell Acute Lymphoblastic Leukemia with t(12;21). Kaczmarska A; Derebas J; Pinkosz M; Niedźwiecki M; Lejman M Cells; 2023 Jan; 12(3):. PubMed ID: 36766699 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]